Joshua is an 80-year-old man who had been stable on coumadin for 12 months, consistently demonstrating an INR of 2.2 to 3.1. Today, Joshua presented with an INR of 21.4, which results in immediate admission...
Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
We previously met Louis, a healthy 68-year-old male who currently takes no medications but has been reluctant to start statin use due to concerns that it may cause dementia. Today, you receive a call from...
